BE
Bonness Enterprises Portfolio holdings
AUM
$305M
This Quarter Return
+7.18%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$147M
AUM Growth
+$147M
(+5.4%)
Cap. Flow
-$854K
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
55.67%
Holding
46
New
–
Increased
–
Reduced
4
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
GSK
GSK
|
$425K |
| 2 |
GE Aerospace
GE
|
$422K |
| 3 |
Exxon Mobil
XOM
|
$5.85K |
| 4 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
$34 |
Sector Composition
| 1 | Financials | 29.44% |
| 2 | Healthcare | 26.15% |
| 3 | Technology | 20.94% |
| 4 | Industrials | 6.8% |
| 5 | Materials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$144B
| $34.4M | 23.34% |
610,608
| – | – |
|
2
Stryker
SYK
$149B
| $11.7M | 7.96% |
75,700
| – | – |
|
3
Johnson & Johnson
JNJ
$429B
| $5.73M | 3.89% |
41,038
| – | – |
|
4
DuPont de Nemours
DD
$31.7B
| $5.52M | 3.74% |
77,473
| – | – |
|
5
Microsoft
MSFT
$3.75T
| $5.01M | 3.4% |
58,600
| – | – |
|
6
IBM
IBM
$225B
| $4.52M | 3.07% |
29,464
| – | – |
|
7
Intel
INTC
$106B
| $4.2M | 2.85% |
90,950
| – | – |
|
8
Unilever
UL
$156B
| $3.98M | 2.7% |
71,940
| – | – |
|
9
AbbVie
ABBV
$374B
| $3.64M | 2.47% |
37,600
| – | – |
|
10
Bristol-Myers Squibb
BMY
$96.5B
| $3.32M | 2.25% |
54,100
| – | – |
|
11
Emerson Electric
EMR
$73.9B
| $3.1M | 2.11% |
44,500
| – | – |
|
12
Cisco
CSCO
$268B
| $3.09M | 2.1% |
80,700
| – | – |
|
13
Nucor
NUE
$33.6B
| $3.07M | 2.09% |
48,350
| – | – |
|
14
Applied Materials
AMAT
$126B
| $2.91M | 1.98% |
57,000
| – | – |
|
|
15
GE Aerospace
GE
$292B
| $2.87M | 1.95% |
164,578
-24,200
| -13% | -$422K |
|
16
Pfizer
PFE
$142B
| $2.85M | 1.93% |
78,608
| – | – |
|
17
Merck
MRK
$214B
| $2.78M | 1.89% |
49,400
| – | – |
|
18
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.73M | 1.85% |
13,750
| – | – |
|
19
Apple
AAPL
$3.41T
| $2.49M | 1.69% |
14,735
| – | – |
|
20
Thermo Fisher Scientific
TMO
$184B
| $2.37M | 1.61% |
12,500
| – | – |
|
21
Marsh & McLennan
MMC
$101B
| $2.18M | 1.48% |
26,800
| – | – |
|
22
Masco
MAS
$15.2B
| $2.17M | 1.47% |
49,300
| – | – |
|
23
Verizon
VZ
$185B
| $2.01M | 1.36% |
37,887
| – | – |
|
24
Abbott
ABT
$229B
| $1.98M | 1.34% |
34,700
| – | – |
|
25
Oracle
ORCL
$633B
| $1.92M | 1.31% |
40,700
| – | – |
|